Search results
Xometry, Inc. (NASDAQ:XMTR) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoXometry, Inc. (NASDAQ:XMTR) Q1 2024 Earnings Call Transcript May 9, 2024 Xometry, Inc. isn’t one of...
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoXeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q1 2024 Earnings Call Transcript May 9, 2024 Xeris...
Earnings call: Bioventus posts robust Q1 performance, raises 2024 outlook
Investing.com· 5 days agoBioventus Inc. (NASDAQ: BVS ) has reported a robust first quarter in 2024, with a 15% organic...
Q1 2024 OPKO Health Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 4 days ago...in late Q4 2023, which now offers clients an internal solution with fast turnaround times for timely decision-making that we continue to expand our testing portfolio and expect new tests in Q2 to complement our current OncoCyte advance and risk portfolio, which will enable GenPath oncology to...
Palo Alto Networks unveils new AI-powered security solutions to tackle advanced threats -...
SiliconANGLE· 4 days agoPalo Alto Networks Inc. today announced a suite of new security solutions powered by its Precision AI technology that are designed to protect enterprises against artificial ...
Palo Alto Networks Launches New Security Solutions Infused with Precision AI to Defend Against...
Morningstar· 4 days agoNew AI Access Security, AI-SPM and AI Runtime Security solutions enable companies to safely adopt AI News Summary: Precision AI™ is a proprietary, innovative AI system that ...
CJ Biomaterials Expands PHA Offering, Introduces New Semi-Crystalline PHA Biopolymer at NPE 2024
Digital Journal· 3 days ago"PHACT S1000P offers excellent biodegradability under various conditions, including anaerobic, aquatic, and compost environments. This versatility enables us to offer tailored ...
Janssen Pharms., Inc. v. Tolmar, Inc. - Invega Sustenna® (Paliperidone Extended-Release Suspension)...
JD Supra· 4 days agoNature of the Case and Issue(s) Presented: Janssen developed its injectable schizophrenia treatment drug product in response to problems associated with oral administration of antipsychotic ...
Zacks Industry Outlook Highlights BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand
Zacks via Yahoo Finance· 5 days agoBPMC’s shares have risen 16.2% in the past year. Immunovant, Inc. is a clinical-stage...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 6 days agoChicago, May 06, 2024 (GLOBE NEWSWIRE) -- Automotive Turbocharger market is estimated to grow from USD 15.2 billion in 2024 to USD 22.9 billion by 2030 with a CAGR of 7.1% over the forecast period, according to a new report by MarketsandMarkets
